Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia, G Triolo|Arthritis & Rheumatism|2011Cited by 128
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life SettingMariele Gatto, Roberto Gerli, Giacomo Emmi et al.|Arthritis & Rheumatology|2020Cited by 113
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndromeFrancesco Ciccia, G Triolo|Lara D. Veeken|2014Cited by 51
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activityFrancesco Ciccia, G Triolo|Lara D. Veeken|2014Cited by 15